SAC goes pink.
Recently, SAC Capital (Steven A Cohen's fund) initiated a fairly large position in Vaxgen (VXGN), a biodefense play. Time to follow the leader?
posted by internet @ 5:45 PM
investmentyearbook.com
Random thoughts and rhetorical questions from yet another blog focused on business trends for an audience of one, me. Just jotting thoughts, notes, etc. Nothing much more than that. There are known knowns. These are things we know that we know. There are known unknowns. That is to say, there are things that we know we don't know. But there are also unknown unknowns. There are things we don't know we don't know... ~The ironic zen of Donald Rumsfeld
Sunday, February 26, 2006
Recently, SAC Capital (Steven A Cohen's fund) initiated a fairly large position in Vaxgen (VXGN), a biodefense play. Time to follow the leader?
<< Home